FindTrial
Sign In

Multisystemic inflammatory syndrome in children (MIS-C) in COVID pandemic

Clinical profile and outcome of Multisystemic inflammatory syndrome in children (MIS-C) in COVID pandemic â?? An observational study from a paediatric tertiary care centre - MIS-C

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029061
Enrollment
200
Registered
2020-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

ICH HC Madras Medical College Chennai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children admitted to PICU with MIS-C

Exclusion criteria

Exclusion criteria: Non MIS-C Children

Design outcomes

Primary

MeasureTime frame
To identify the different phenotypes of MIS-C. spectrum Time forn ormalisation of clinical symptoms of fever and rash Time for normalization of lab abnormalities of inflammatory markers ESR CRP Timepoint: 3, 6, 9 ,12 months—

Secondary

MeasureTime frame
Incidence of complications related to therapy Length of hospital stay One year follow up for different organ system involvement Mortality (all-cause) Timepoint: 3, 6, 9 ,12 months—

Countries

India

Contacts

Public ContactDr V Poovazhagi

Institute of Child health,

elil.raghu@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026